Annual Drug Patent Expirations for TEGSEDI Tegsedi is a drug marketed by Akcea Theraps and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Akcea Theraps drug TEGSEDI appeared first on…
New patent expiration for Akcea Theraps drug TEGSEDI Read Post »
QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of September 3, 2023 Read Post »
QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of September 3, 2023 Read Post »
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Abbvie drug LATISSE appeared first on …
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Abbvie drug LATISSE appeared first on …
Annual Drug Patent Expirations for VYVANSE Vyvanse is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from one supplier. There are eighteen…
The post New patent expiration for Takeda Pharms drug VYVANSE appeared first …
New patent expiration for Takeda Pharms drug VYVANSE Read Post »
VYVANSE (lisdexamfetamine dimesylate) Takeda pharms usa Patent: 7,718,619 Expiration: Aug 24, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expir…
Drug Patent Expirations for the Week of August 20, 2023 Read Post »
Annual Drug Patent Expirations for CUVPOSA Cuvposa is a drug marketed by Merz Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Merz Pharms drug CUVPOSA appeared first on Dru…
New patent expiration for Merz Pharms drug CUVPOSA Read Post »
Annual Drug Patent Expirations for ZERIT+XR Zerit Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. There is one patent protecting this drug. The…
The post New patent expiration for Bristol Myers drug ZERIT XR appeared first on …
New patent expiration for Bristol Myers drug ZERIT XR Read Post »
ZERIT XR (stavudine) Bristol myers squibb Patent: 7,135,465 Expiration: Aug 18, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for the…
Drug Patent Expirations for the Week of August 13, 2023 Read Post »